Literature DB >> 25544991

The early history of the eosinophil.

A B Kay1.   

Abstract

In 1879 Paul Ehrlich published his technique for staining blood films and his method for differential blood cell counting using coal tar dyes and mentions the eosinophil for the first time. Eosin is a bright red synthetic dye produced by the action of bromine on fluorescein and stains basic proteins due to its acidic nature. It was discovered in 1874 by Heinrich Caro, Director of the German chemical company Badische Anilin- und Soda-Fabrik. Ehrlich introduced the term 'eosinophil' to describe cells with granules (which he called alpha-granules) having an affinity for eosin and other acid dyes. He also observed black-staining, indulinophilic, beta-granules in bone marrow-derived eosinophils, which were probably immature crystalloid granules in eosinophil myelocytes. Ehrlich described the features of the alpha-granule and the cell's distribution in various species and tissues. He speculated correctly that the alpha-granule contents were secretory products and described several causes of eosinophilia including asthma, various skin diseases, helminths and reactions to medications. However, the cell was almost certainly observed by others before Ehrlich. In 1846 Thomas Wharton Jones (1808-1891) described 'granule blood cells' in the lamprey, frog, fowl, horse, elephant and man. He 'borrowed' the term granule cell from Julius Vogel (1814-1880) who had observed similar cells in inflammatory exudates. Vogel in turn was aware of the work of the Gottlieb (Théophile) Gluge (1812-1898) who used the term 'compound inflammatory globules' to describe cells in pus and serum. Almost 20 years before Ehrlich developed his staining methods, Max Johann Sigismund Schultze (1825-1874) performed functional experiments on coarse granular cells using a warm stage microscopic technique and showed they had amoeboid movement and phagocytic abilities. Although these early investigators recognised distinct granular cells Ehrlich's use of stains was a landmark contribution, which heralded modern studies on eosinophils and other blood leucocytes.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25544991     DOI: 10.1111/cea.12480

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  23 in total

1.  Experimental Modeling of Eosinophil-Associated Diseases.

Authors:  Sathisha Upparahalli Venkateshaiah; Murli Manohar; Hemanth Kumar Kandikattu; Anil Mishra
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 3.  Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy.

Authors:  Matthew P Giannetti; Juan C Cardet
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

4.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

Review 5.  Eosinophils: Nemeses of Pulmonary Pathogens?

Authors:  Kim S LeMessurier; Amali E Samarasinghe
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-19       Impact factor: 4.806

Review 6.  Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.

Authors:  Shigeharu Ueki; Nobuo Ohta; Masahide Takeda; Yasunori Konno; Makoto Hirokawa
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

Review 7.  Contemporary understanding of the secretory granules in human eosinophils.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  J Leukoc Biol       Date:  2018-05-11       Impact factor: 4.962

8.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

Review 9.  Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.

Authors:  Leena George; Christopher E Brightling
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

Review 10.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.